Skip to main content

Table 1 Subject characteristics

From: The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease

Subject

Age

Gender

FEV1 (% predicted)

COPD severity

Lobectomy site

Current tobacco use

Years since last tobacco use

Total pack-years

ICSa use

LABAb use

1

82

Male

1.28 (64.7)

Moderate

Left upper lobe

No

22

NAc

Yes

No

2

77

Male

1.65 (63.1)

Moderate

Right upper lobe

No

0.057

100

No

No

3

69

Male

2.55 (71.8)

Moderate

Right upper lobe

Yes

0

40

No

No

4

73

Male

2.04 (88.9)

Mild

Right middle lobe

No

20

30

Yes

No

5

79

Male

1.99 (78.5)

Moderate

Left upper lobe

Yes

0

40

Yes

No

6

79

Male

2.03 (69.8)

Moderate

Right upper lobe

No

30

45

No

No

7

54

Male

3.55 (90.3)

Mild

Right upper lobe

Yes

0

80

No

No

8

66

Female

2.01 (90.9)

Mild

Left upper lobe

Yes

0

18

No

No

9

72

Female

2.44 (67.1)

Moderate

Right lower lobe

No

12

30

No

No

  1. aICS inhaled corticosteroid
  2. bLABA long-acting beta-agonist
  3. cNA not available